OakChart

biote Corp

BTMDHealthcare·Medical Care Facilities·USA·Micro·NASD·Nov 11 • 3:59 PM ET

1.09+0.01 (0.93%)
2026-11-12 01:20 CET
Market cap
30.97 USD m
Revenue, TTM
178.91 USD m
Net income, TTM
-1.93 USD m
Free cash flow, TTM
7.41 USD m
EPS diluted, TTM
-0.09
P/E
-
Compare

Price

BTMD against its 20, 50 and 200-day averages
2050200missearnings
1.001.502.002.501.6M3.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BTMDclose 1.0920-day 1.1150-day 1.22200-day 1.781.0952w low

62.4% under the 52-week high of 2.90 on 11 Dec 2025. 52-week low 0.99 on 5 Nov 2026. Last 15 sessions, 25.8% high to low

Volume 0.10× normal · the line is the 50-bar volume average

Profile

BTMD
52-week range, 5% of the way up
0.992.90

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.

Employees223
IPOApr 28, 2021
Beta1.74
ATR, 14d0.10
Rel volume0.10
Short float3.61%
Insider own18.76%
Inst own61.68%

Snapshot

6 groups

Valuation

Index-
Market Cap60.74M
Enterprise Value187.47M
Income-1.93M
Sales178.91M
Book/sh-2.42
Cash/sh0.16
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees223
IPOApr 28, 2021

Ratios

P/E-
Forward P/E7.79
PEG-
P/S0.34
P/B-
P/C6.86
P/FCF8.20
EV/EBITDA9.44
EV/Sales1.05
Quick Ratio0.73
Current Ratio1.37
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.09
EPS next Y0.14
EPS next Q0.01
EPS this Y-97.30%
EPS next Y600.00%
EPS next 5Y-17.87%
EPS past 3/5Y- 11.37%
Sales past 3/5Y5.23% 10.52%
EPS Y/Y TTM-108.33%
Sales Y/Y TTM-8.55%
EPS Q/Q-93.36%
Sales Q/Q-9.64%
EarningsNov 04 AMC
EPS/Sales Surpr.300.00% -1.54%

Ownership

Insider Own18.76%
Insider Trans2.00%
Inst Own61.68%
Inst Trans-9.56%
ROA-1.81%
ROE-
ROIC-3.29%
Gross Margin65.80%
Oper. Margin8.90%
Profit Margin-1.08%
SMA20-1.60%
SMA50-10.31%
SMA200-38.83%
Trades-

Technical

Shs Outstand27.04M
Shs Float23.30M
Short Float3.61%
Short Ratio4.42
Short Interest0.84M
52W High2.90 -62.41%
52W Low0.99 10.09%
Volatility9.90% 9.70%
ATR (14)0.10
RSI (14)45.47
Beta1.74
Rel Volume0.10
Avg Volume190.35K
Volume19,135

Performance

Perf Week-11.38%
Perf Month4.81%
Perf Quarter-26.85%
Perf Half Y-46.31%
Perf YTD-58.08%
Perf Year-58.16%
Perf 3Y-75.94%
Perf 5Y-88.85%
Perf 10Y-
Recom1.40
Target Price2.22
Prev Close1.08
Price1.09
Change %0.93%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Aug 07, 2025DowngradeRB. Riley SecuritiesBuy → Neutral$4+267.0%
Dec 16, 2024InitiatedCCraig HallumBuy
Feb 20, 2024InitiatedRB. Riley SecuritiesBuy$9+725.7%
Feb 01, 2024InitiatedJJefferiesBuy
Jun 24, 2022InitiatedCCowenOutperform$11+909.2%
Jun 23, 2022InitiatedRROTH CapitalBuy$9+725.7%

Peers

Mkt cap
TickerCompanyMkt cap
WWWW International Inc130.49M
JYNTJoint Corp93.09M
LFMDLifeMD Inc85.80M
AIRSAirsculpt Technologies Inc59.55M
TXMDTherapeuticsMD Inc21.41M
HIMSHims & Hers Health Inc4.86B
EOLSEvolus Inc491.11M
DAREDare Bioscience Inc13.65M
INMDInmode Ltd790.08M
NATRNature's Sunshine Products Inc178.66M

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Beer Marc DExecutive ChairmanAug 10 '26Buy1.53115,950177,404223,744Aug 12 04:25 PM
Beer Marc DExecutive ChairmanAug 11 '26Buy1.5516,00024,800239,744Aug 12 04:25 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.010-0.005-0.23043.3344.014
2026Q22026-08-05-0.2300.027-0.22944.2046.123
2026Q12026-05-060.0600.0480.06344.9446.024
2025Q42026-03-110.0600.0400.06346.4145.834
2025Q32025-11-050.2200.0780.22347.9647.854
2025Q22025-08-060.1000.0800.10048.8649.454
2025Q12025-05-070.3700.0780.37148.9947.255
2024Q42025-03-120.1000.1140.09949.8351.205
2024Q32024-11-120.3300.1180.33251.3851.384
2024Q22024-08-08-0.1900.087-0.19149.1749.063
2024Q12024-05-07-0.0600.050-0.06046.8045.684
2023Q42024-03-120.1800.0830.12245.7045.814
2023Q32023-11-070.2400.0750.24345.5647.902
2023Q22023-08-10-0.2500.097-0.24849.2646.763
2023Q12023-05-09-0.3900.090-0.38744.8443.372
2022Q42023-03-280.1800.1400.02844.4943.832

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY-0.1201.710-0.120164.96164.3
2023FY0.130-0.0470.129185.4185.47
2024FY0.0900.2320.092197.19198.56
2025FY0.7400.6650.790192.22191.65
2026FY-0.020--176.02
2027FY-0.140--181.28
2028FY-0.410--195
2029FY-0.460--206
2030FY-0.490--218

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0540243.6042.6045.40
2026Q4S2026-11-0440044.1043.3845.40
2026Q4S2026-10-2140044.1043.3845.40
2026Q4S2026-10-2040144.1043.3845.40
2026Q4S2026-08-0740444.1043.3845.40
2026Q4S2026-08-0640345.7543.6050.00
2026Q4S2026-07-2140050.3750.0050.98
2026Q4S2026-05-2643050.3750.0050.98
2026Q4S2026-05-1843150.3750.0050.98
2026Q4S2026-05-0753250.5150.0051.07
2026Q4S2026-04-1651249.3747.9551.00
2026Q4S2026-03-1251149.7447.9552.55
2026Q4S2026-03-0230051.3447.9053.53
2026Q4S2026-01-2030151.3447.9053.53

Estimate history

EPS, annual0.3140.431-0.871-0.120.1290.0920.738-0.0878
Period2019202020212022202320242025TTM
EPS, quarterly0.3320.0990.3710.10.2230.0630.063-0.2290.015
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual109.976116.568139.396164.957185.36197.191192.219178.91
Period2019202020212022202320242025TTM
Sales, quarterly51.38449.83448.99248.86347.95646.40844.93544.23243.334
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual67.72867.7289.1629.65534.25531.48630.71327.04
Period2019202020212022202320242025MRQ
Shares, quarterly31.11331.48631.48631.69330.68130.71329.98727.66227.04
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue178.91192.22197.19185.36164.96139.40116.57109.98
Cost of Goods Sold Incl. D&A61.1958.1361.7060.8756.7748.8246.2844.61
Gross Profit117.72134.09135.49124.49108.1890.5870.2865.37
Selling, General and Administrative Excl. Other101.7994.9794.1081.27168.91160.3738.5041.84
Other Operating Expense0.000.000.000.000.000.200.000.00
Operating Income15.9339.1241.3943.22-60.72-70.0031.7823.53
Interest Expense8.7411.8611.006.365.097.882.422.08
Unusual Expense3.99-9.0529.3836.97-66.45-14.35--
Net Income Before Taxes3.1737.581.02-0.121.71-63.5129.3521.38
Income Taxes4.745.990.972.680.39-1.970.190.09
Consolidated Net Income-1.5731.600.05-2.811.32-61.5429.1621.29
Net Income From Continuing Operations-1.9327.053.163.32-0.97-6.6029.1621.29
Net Income-1.9327.053.163.32-0.97-6.6029.1621.29
EPS (Recurring)0.030.560.691.14-5.89-2.200.430.31
EPS (Basic, Before Extraordinaries)-0.080.860.090.13-0.12-0.870.430.31
EPS (Diluted)-0.090.740.090.13-0.12-0.870.430.31
EBITDA19.8542.7944.9646.22-58.28-33.1424.57
Non-Operating Income (Expense)-0.021.270.01-0.021.070.02-0.01-0.07
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.747.096.907.1664.92---
Price To Earnings Ratio--30.46-----
Price To Sales Ratio0.190.501.070.690.180.53--
Gross Margin65.8069.7668.7167.1665.5864.9860.2959.44
Operating Margin8.9020.3520.9923.32-36.81-50.2127.2621.39
Net Margin-1.0814.071.601.79-0.59-4.7325.0219.36
Shares Outstanding27.0430.7131.4934.259.669.1667.7367.73
Market Capitalization30.9730.97202.09167.6737.27388.94389.33-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue43.3344.2344.9446.4147.9648.8648.9949.83
Cost of Goods Sold Incl. D&A14.7916.0614.7615.5914.2914.7213.4615.18
Gross Profit28.5528.1730.1730.8233.6734.1435.5334.66
Selling, General and Administrative Excl. Other26.0226.4925.6723.6124.9822.5725.0824.41
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income2.531.684.507.228.6911.5710.4510.25
Interest Expense2.122.181.972.472.732.852.903.22
Unusual Expense-0.966.62-0.81-0.86-2.502.63-9.938.26
Net Income Before Taxes1.36-7.133.345.608.456.0817.45-1.22
Income Taxes0.800.300.662.99-0.772.151.62-4.70
Consolidated Net Income0.57-7.432.682.629.223.9215.843.48
Net Income From Continuing Operations0.41-6.562.281.958.193.1913.723.70
Net Income0.41-6.562.281.958.193.1913.723.70
EPS (Recurring)-0.01-0.070.050.040.180.160.180.25
EPS (Basic, Before Extraordinaries)0.01-0.230.070.060.260.100.440.12
EPS (Diluted)0.01-0.230.060.060.220.100.370.10
EBITDA3.562.645.498.179.6412.4811.3111.38
Non-Operating Income (Expense)-0.00-0.01-0.01-0.00-0.00-0.01-0.020.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.061.561.391.741.901.731.681.49
Price To Earnings Ratio-4.201.783.273.326.5818.4930.46
Price To Sales Ratio0.190.290.260.420.560.640.621.17
Gross Margin65.8863.6967.1566.4270.2069.8672.5369.54
Operating Margin5.843.7910.0315.5518.1223.6721.3320.56
Net Margin0.94-14.845.074.2117.076.5228.007.43
Shares Outstanding27.0427.6629.9930.7130.6831.6931.4931.49
Market Capitalization30.9757.3343.6183.9099.84132.95110.13202.09

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments24.1239.3489.0079.23-17.21-
Short Term Receivables7.687.708.176.95-4.72-
Inventories19.4217.6520.9512.06-4.32-
Other Current Assets3.453.434.222.94-1.57-
Total Current Assets54.6768.13122.34101.18-27.82-
Net Property, Plant & Equipment13.4510.223.103.56-2.17-
Total Investments and Advances0.000.000.000.00-0.00-
Intangible Assets14.6215.214.975.07-2.60-
Deferred Tax Assets24.7928.7424.881.84---
Other Assets0.070.070.000.00-0.00-
Total Assets107.61122.37155.29111.64-32.59-
Short Term Debt Incl. Current Port. of LT Debt25.3431.356.566.42-5.24-
Accounts Payable6.835.814.164.11-2.44-
Income Tax Payable-0.000.02----
Other Current Liabilities12.8214.3511.488.24-4.03-
Total Current Liabilities44.9951.5122.2118.77-11.71-
Long Term Debt103.08148.39108.31114.01-37.12-
Provision for Risks Charges4.1117.1441.1032.11-0.00-
Other Liabilities5.837.5320.225.03-0.84-
Total Liabilities158.01224.57191.84169.92-49.66-
Non-Equity Reserves0.000.000.000.00-0.00-
Preferred Stock - Carrying Value0.000.000.000.00-0.00-
Common Equity-58.54-105.93-29.40-44.46--17.07-
Total Shareholders Equity-58.54-105.93-29.40-44.46--17.07-
Accumulated Minority Interest8.143.73-7.15-13.81-0.00-
Total Equity-50.40-102.20-36.55-58.27--17.07-
Total Liabilities & Stockholders Equity107.61122.37155.29111.64-32.59-
Book Value Per Share-1.91-3.36-0.86-4.60--0.25-
Tangible Book Value Per Share-2.38-3.85-1.00-5.13--0.29-
Full-Time Employees223217194186---
Price to Book Ratio-0.45-1.48-4.33-0.65---
Return on Assets23.522.272.48----
Return on Invested Capital60.727.444.20-1.39-145.51-
Quick Ratio0.780.984.564.75-2.01-
Current Ratio1.221.325.515.39-2.38-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-1.5731.600.05-2.811.32-29.1621.29
Depreciation3.923.673.572.992.44-1.361.04
Other Funds (Non Cash)6.204.2034.5934.9023.64-1.500.63
Funds from Operations13.1243.4535.3135.8126.66-32.0122.96
Extraordinary Item0.000.000.000.000.00-0.000.00
Changes in Working Capital0.86-8.259.93-8.93-35.81--5.362.62
Cash from Operating Activities13.9835.1945.2426.88-9.16-26.6625.58
Capital Expenditures-9.19-6.86-6.96-2.71-1.84--1.39-1.67
Net Assets From Acquisitions0.000.00-11.840.000.00---
Sale of Fixed Assets and Businesses0.000.000.000.000.00---
Purchase or Sale of Investments0.000.000.000.000.00---
Purchase of Investments0.000.000.000.000.00---
Sale Or Maturity of Investments0.000.000.000.000.00---
Other Uses0.000.000.000.000.00-0.000.00
Other Sources0.000.000.000.000.00---
Cash from Investing Activities-9.19-6.86-18.80-2.71-1.84--1.39-1.67
Cash Dividends Paid-1.17-1.73-4.74-8.69-12.89--13.32-56.63
Change in Capital Stock-7.11-3.00-2.930.560.44-0.000.00
Repurchase of Common Pref Stock-7.22-3.37-5.600.000.00-0.000.00
Sale of Common Pref Stock0.120.372.670.560.44-0.000.00
Proceedsfrom Stock Options-0.030.000.280.140.44-0.000.00
Issuance or Reduction of Debt, Net60.76-38.83-68.41-6.2580.34--5.2342.86
Change in Long Term Debt60.76-38.83-68.41-6.2580.34--5.0043.08
Issuance of Long Term Debt138.255.000.000.00120.96-0.0064.29
Reduction of Long Term Debt-77.49-43.83-68.41-6.25-40.62--5.00-21.21
Net Financing Active Other Cash Flow-76.480.000.000.00-4.43-0.000.00
Other Financing Activities Uses-76.480.000.000.00-16.72-0.000.00
Cash from Financing Activities-23.99-43.55-76.08-14.3863.46--18.55-13.78
Exchange Rate Effect0.000.01-0.02-0.020.00-0.01-0.01
Net Change in Cash-19.20-15.22-49.669.7752.47-6.7210.12
Free Cash Flow7.4130.1838.8126.52-9.49-26.3624.87
Preferred Dividends (Cash Flow)-0.000.000.000.00-0.000.00
Price to Free Cash Flow5.323.356.227.12----
Deferred Taxes & Investment Tax Credit-3.98-2.900.72-0.74-0.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments8.8511.175.3224.1228.0519.60
Short Term Receivables9.589.617.407.688.319.17
Inventories19.3518.6920.3019.4217.5616.16
Other Current Assets3.993.573.333.453.214.57
Total Current Assets41.7643.0436.3654.6757.1249.50
Net Property, Plant & Equipment22.3019.6913.2613.4512.9012.91
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets14.2714.3814.8614.6213.9014.30
Deferred Tax Assets23.2924.5224.4824.7927.3228.02
Other Assets0.070.070.070.070.070.07
Total Assets101.70101.7089.03107.61111.32104.80
Short Term Debt Incl. Current Port. of LT Debt3.903.836.8625.3437.7134.64
Accounts Payable7.746.588.246.834.363.86
Income Tax Payable--0.04---
Other Current Liabilities18.8619.6913.0912.8214.2412.04
Total Current Liabilities30.5030.1028.2344.9956.3150.54
Long Term Debt123.92124.81101.56103.08109.16119.03
Provision for Risks Charges0.000.001.964.115.368.28
Other Liabilities4.874.985.245.835.965.79
Total Liabilities159.29159.89136.99158.01176.79183.64
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-65.35-65.79-56.09-58.54-72.75-85.10
Total Shareholders Equity-65.35-65.79-56.09-58.54-72.75-85.10
Accumulated Minority Interest7.757.608.148.147.286.26
Total Equity-57.60-58.19-47.95-50.40-65.47-78.84
Total Liabilities & Stockholders Equity101.70101.7089.03107.61111.32104.80
Book Value Per Share-2.42-2.38-1.87-1.91-2.37-2.69
Tangible Book Value Per Share-2.94-2.90-2.37-2.38-2.82-3.14
Full-Time Employees---223--
Price to Book Ratio-0.45-1.01-0.71-1.10-1.12-1.41
Return on Assets-1.815.6714.6923.5227.0931.67
Return on Invested Capital0.69-11.125.014.3922.499.39
Quick Ratio0.730.810.570.780.700.66
Current Ratio1.371.431.291.221.010.98

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income0.57-7.432.682.629.223.92
Depreciation1.030.960.980.950.950.91
Other Funds (Non Cash)1.643.17-1.592.991.036.12
Funds from Operations4.52-2.751.869.4910.9511.73
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.831.582.04-1.923.12-4.65
Cash from Operating Activities3.69-1.183.907.5714.077.09
Capital Expenditures-3.03-2.62-1.17-2.36-0.69-1.96
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-3.03-2.62-1.17-2.36-0.69-1.96
Cash Dividends Paid-0.01-0.62-0.41-0.14-0.01-0.89
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-1.36-4.75-1.070.07-3.370.30
Repurchase of Common Pref Stock-1.36-4.79-1.070.00-3.370.00
Sale of Common Pref Stock0.000.050.000.070.000.30
Proceedsfrom Stock Options0.050.000.00-0.070.000.07
Issuance or Reduction of Debt, Net-1.60116.57-20.06-34.14-1.56-1.56
Change in Long Term Debt-1.60116.57-20.06-34.14-1.56-1.56
Issuance of Long Term Debt-0.82126.577.505.000.000.00
Reduction of Long Term Debt-0.78-10.00-27.56-39.14-1.56-1.56
Net Financing Active Other Cash Flow0.00-101.560.0025.080.00-25.08
Other Financing Activities Uses0.00-101.560.0025.080.00-25.08
Cash from Financing Activities-2.979.65-21.54-9.13-4.93-27.23
Exchange Rate Effect-0.000.000.000.000.000.01
Net Change in Cash-2.325.85-18.80-3.928.45-22.10
Free Cash Flow1.11-3.733.546.4913.575.28
Price to Free Cash Flow5.322.891.772.823.373.90

Revenue breakdown

Contract-Term Services2024: 1.23M 2025: 1.36M
Dietary Supplements2024: 36.02M 2025: 42.88M
Disposable Trocars Product2024: 4.35M 2025: 4.85M
Other Service2024: 2.27M 2025: 2.86M
Pellet Procedures Product2024: 150.33M 2025: 137.04M
Shipping Fees And Other Product2024: 1.55M 2025: 2.15M
Training Service2024: 1.46M 2025: 1.08M
Consolidation, Policy2024: 991.00K 2025: 1.02M
United States2024: 196.20M 2025: 191.20M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.61%0.8M23.3M202.60K
2026-10-155.07%1.2M23.3M225.74K
2026-09-304.65%1.1M23.3M234.20K
2026-09-155.50%1.3M23.3M319.89K
2026-08-315.86%1.4M23.8M312.11K
2026-08-142.55%0.7M25.9M284.02K
2026-07-311.96%0.5M27.5M282.78K
2026-07-152.11%0.6M27.5M274.83K
2026-06-302.01%0.6M27.5M303.29K
2026-06-154.68%1.3M27.5M256.14K
2026-05-295.11%1.4M27.6M267.87K
2026-05-155.87%1.6M27.6M251.70K
2026-04-305.07%1.5M29.2M242.54K
2026-04-155.77%1.7M29.2M241.24K
2026-03-315.42%1.6M29.4M214.33K
2026-03-135.44%1.6M29.3M173.77K
2026-02-274.91%1.4M29.3M145.24K
2026-02-135.45%1.6M29.3M151.29K
2026-01-305.52%1.6M29.3M145.17K
2026-01-155.04%1.5M29.3M140.75K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-09-18SCHEDULE 13G/ASEC
2026-09-01SCHEDULE 13G/ASEC
2026-08-28SCHEDULE 13GSEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-07-27SCHEDULE 13G/ASEC
2026-06-178-K/A2026-06-12SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-028-KCurrent report2026-05-27SEC
2026-05-188-KCurrent report2026-05-12SEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-13SCHEDULE 13G/ASEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-05-044Statement of changes in beneficial ownership of securities2026-05-01SEC
2026-05-043Initial statement of beneficial ownership of securities2026-04-27SEC
2026-04-14S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-04-034Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-034Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-038-KCurrent report2026-04-03SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08202.20K200
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
325 CAPITAL LLC14.99%
Bandera Partners LLC6.81%
VANGUARD CAPITAL MANAGEMENT LLC3.64%
ACADIAN ASSET MANAGEMENT LLC2.05%
DIMENSIONAL FUND ADVISORS LP1.48%
MILLENNIUM MANAGEMENT LLC1.44%
BlackRock, Inc.1.21%
CITADEL ADVISORS LLC0.99%
RICE HALL JAMES & ASSOCIATES, LLC0.87%
GEODE CAPITAL MANAGEMENT, LLC0.84%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.74%
Fidelity Small Cap Index Fund0.91%
VANGUARD EXTENDED MARKET INDEX FUND0.82%
U.S. SMALL CAP PORTFOLIO0.54%
VANGUARD RUSSELL 2000 INDEX FUND0.48%
U.S. MICRO CAP PORTFOLIO0.41%
Fidelity Extended Market Index Fund0.39%
iShares Micro-Cap ETF0.33%
Dimensional U.S. Small Cap ETF0.19%
Clearwater Select Equity Fund0.18%

OakChart. BTMD. Cached 15 minutes.